I. Introduction
Cervical cancer is a common occurring condition primarily caused by the infection of some types of human papillomavirus. According to a report by WHO published in 2012 [1], cervical cancer is the second most common gynecological cancer in less developed regions. In Australia, current reports estimate 885 new cases of cervical cancer to be diagnosed in 2015, and 250 deaths due to this disease [2]. Currently, Pap smear test [3] is an important routine screening in the early detection of this type of cancer. In this screening process, a clinician collects a sample of cells from the uterine cervix, which are then stained using the Papanicolaou technique to enable visual inspection on a microscope, where the appearance of each cell provides features that indicate the stages of cervical cancer. The development of automated cell deposition techniques, such as monolayer preparations, has facilitated both manual and automated slide analysis techniques by removing a large portion of blood, mucus, and other debris, reducing cellular overlap and producing specimens that are more likely to occur in a single focal plane. However, the manual analysis of cell abnormalities on Pap-stained specimens is a time-consuming and error-prone procedure, where sensitivity is affected by the number of cells inspected, the overlap among these cells, the poor contrast of the cell cytoplasm, and the presence of mucus, blood, and inflammatory cells [4] (see examples in Fig. 1).